Si-Bone (SIBN) Liabilities and Shareholders Equity (2017 - 2026)
Si-Bone (SIBN) recorded quarterly Liabilities and Shareholders Equity of $242.7 million in Q1 2026, up 1.75% quarter-over-quarter from $238.6 million in Q4 2025, and up 6.79% on a YoY basis from $227.3 million in Q1 2025.
Si-Bone (SIBN) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
Si-Bone's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $242.7 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 6.79% year-over-year to $242.7 million; the TTM figure through Mar 2026 stood at $946.5 million (up 4.17% YoY), while the FY2025 annual figure was $238.6 million, up 3.52% from the prior year.
- Liabilities and Shareholders Equity was $242.7 million for Q1 2026 at Si-Bone, up from $238.6 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $242.7 million in Q1 2026 to a low of $149.1 million in Q1 2023.
- Historically, Liabilities and Shareholders Equity has averaged $210.7 million across 5 years, with a median of $227.3 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity fell 19.86% in 2022, then jumped 50.07% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $157.6 million in 2022, then soared by 46.25% to $230.4 million in 2023, then gained by 0.01% to $230.4 million in 2024, then increased by 3.52% to $238.6 million in 2025, then rose by 1.75% to $242.7 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $242.7 million (Q1 2026), $238.6 million (Q4 2025), and $234.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | 242.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 242.72 Mn |
| Dec 31, 2025 | 238.56 Mn |
| Sep 30, 2025 | 234.27 Mn |
| Jun 30, 2025 | 230.92 Mn |
| Mar 31, 2025 | 227.28 Mn |
| Dec 31, 2024 | 230.44 Mn |
| Sep 30, 2024 | 227.00 Mn |
| Jun 30, 2024 | 223.84 Mn |
| Mar 31, 2024 | 223.71 Mn |
| Dec 31, 2023 | 230.43 Mn |
| Sep 30, 2023 | 230.88 Mn |
| Jun 30, 2023 | 233.83 Mn |
| Mar 31, 2023 | 149.08 Mn |
| Dec 31, 2022 | 157.55 Mn |
| Sep 30, 2022 | 158.27 Mn |
| Jun 30, 2022 | 166.15 Mn |
| Mar 31, 2022 | 176.85 Mn |
| Dec 31, 2021 | 190.51 Mn |
| Sep 30, 2021 | 193.97 Mn |
| Jun 30, 2021 | 207.33 Mn |